Hyaluronan in intestinal homeostasis and inflammation: Implications for fibrosis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 301, Issue 6, 2011, Pages

  de la Motte, Carol A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Colitis; Extracellular matrix; Mesenchymal cells

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

CELL DIFFERENTIATION; COLITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; HUMAN; INTESTINAL FIBROSIS; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; WOUND HEALING;

ANIMALS; ENTEROCOLITIS; FIBROSIS; HOMEOSTASIS; HUMANS; HYALURONIC ACID; INFLAMMATION;

EID: 82455175828     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00063.2011     Document Type: Review

References (42)

1. Abatangelo G, Martelli M, Vecchia P. Healing of hyaluronic acidenriched wounds: histological observations. J Surg Res 35: 410-416, 1983.
2. Boyce DE, Thomas A, Hart J, Moore K, Harding K. Hyaluronic acid induces tumour necrosis factor-alpha production by human macrophages in vitro. Br J Plast Surg 50: 362-368, 1997.
3. Day AJ, Prestwich GD. Hyaluronan-binding proteins: tying up the giant. J Biol Chem 277: 4585-4588, 2002.
4. de la Motte CA, Hascall VC, Calabro A, Yen-Lieberman B, Strong SA. Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly I:C. J Biol Chem 274: 30747-30755, 1999.
5. de la Motte C, Hascall VC, Drazba J, Bandyopadhyay S, Strong SA. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyI:C:inter-_-trypsin inhibitor is crucial to structure and function. Am J Pathol 163: 121-133, 2003.
6. de la Motte C, Nigro J, Vasanji A, Rho H, Kessler S, Bandyopadhyay S, Danese S, Fiocchi C, Stern R. Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines and chemokines. Am J Pathol 174: 2254-2264, 2009.
7. Harada H, Takahashi M. CD44-dependent intracellular, and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem 282: 5597-5607, 2007.
8. Jobe KL, Odman-Ghazi SO, Whalen MM, Vercruysse KP. Interleukin-12 release from macrophages by hyaluronan, chondroitin sulfate A and chondroitin sulfate C oligosaccharides. Immunol Lett 89: 99-109, 2003.
9. Johnson P, Ruffell B. CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets 8: 208-220, 2009.
10. Kessler S, Rho H, West G, Fiocchi C, Drazba J, de la Motte C. Hyaluronan (HA) deposition precedes and promotes leukocyte recruitment in intestinal inflammation. Clin Transl Sci 1: 57-61, 2008.
11. Kobayashi H, Terao T. Hyaluronic acid-specific regulation of cytokines by human uterine fibroblasts. Am J Physiol Cell Physiol 273: C1151-C1159, 1997.
12. Lauer ME, Mukhopadhyay D, Fulop C, de la Motte CA, Majors AK, Hascall VC. Primary murine airway smooth muscle cells exposed to poly I:C or tunicamycin synthesize a leukocyte-adhesive hyaluronan matrix. J Biol Chem 284: 5299-5312, 2009.
13. Li Y, Jiang D, Liang J, Meltzer EB, Gray A, Miura R, Wogensen L, Yamaguchi Y, Noble PW. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J Exp Med 208: 1459-1471, 2011.
14. Majors AK, Austin RC, de la Motte CA, Pyeritz RE, Hascall VC, Kessler SP, Sen G, Strong SA. Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion. J Biol Chem 278: 47223-47231, 2003.
15. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 98: 2403-13, 1996.
16. Meran S, Thomas DW, Stephens P, Enoch S, Martin J, Steadman R, Phillips AO. Hyaluronan facilitates transforming growth factor-beta1-mediated fibroblast proliferation. J Biol Chem 283: 6530-6545, 2008.
17. Miyake K, Underhill CB, Lesley J, Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172: 69-75, 1990.
18. Noble PW, Lake FR, Henson PM, Riches DWH. Hyaluronate activation of CD44 induces insulin-like growth factor-l expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 91: 23688-23677, 1993.
19. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 21: 25-29, 2002.
20. Nyberg A, Engström-Laurent A, Lööf L. Serum hyaluronate in primary biliary cirrhosis-a biochemical marker for progressive liver damage. Hepatology 8: 142-146, 1988.
21. Powell JD, Horton MR. Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal. Immunol Res 31: 207-218, 2005.
22. Rieder F, Fiocchi C. Intestinal fibrosis in IBD-a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol 6: 228-235, 2009.
23. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 177: 1272-1281, 2006.
24. Selbi W, de la Motte CA, Hascall VC, Day AJ, Bowen T, Phillips AO. Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney Int 70: 1287-1295, 2006.
25. Shimada M, Yanai Y, Okazaki T, Noma N, Kawashima I, Mori T, Richards JS. Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization. Development 135: 2001-2011, 2008.
26. Shirali AC, Goldstein DR. Activation of the innate immune system by the endogenous ligand hyaluronan. Curr Opin Organ Transplant 13: 20-25, 2008.
27. Siegelman MH, DeGrendele HC, Estess P. Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol 66: 315-321, 1999.
28. Simpson RM, Meran S, Thomas D, Stephens P, Bowen T, Steadman R, Phillips A. Age-related changes in pericellular hyaluronan organization leads to impaired dermal fibroblast to myofibroblast differentiation. Am J Pathol 175: 1915-1928, 2009.
29. Simpson RM, Wells A, Thomas D, Stephens P, Steadman R, Phillips A. Aging fibroblasts resist phenotypic maturation because of impaired hyaluronan-dependent CD44/epidermal growth factor receptor signaling. Am J Pathol 176: 1215-1228, 2010.
30. Slevin M, Krupinski J, Gaffney J, Matou S, West D, Delisser H, Savani RC, Kumar S. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 26: 58-68, 2007.
31. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 83: 317-325, 2004.
32. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85: 699-715, 2006.
33. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279: 17079-17084, 2004.
34. Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, Beutler B, Gallo RL. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem 282: 18265-18275, 2007.
35. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Puré E, Henson PM, Noble PW. Resolution of lung inflammation by CD44. Science 296: 155-158, 2002.
36. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195: 99-111, 2002.
37. Veillon P, Gallois Y, Moal V, Fouchard-Hubert I, Charles I, Larcher F, Dib N, Boursier J, Oberti F, Laafi J, Guéchot J, Balan V, Calès P, Lunel-Fabiani F. Assessment of new hyaluronic acid assays and their impact on FibroMeter scores. Clin Chim Acta 412: 347-352, 2011.
38. Webber J, Meran S, Steadman R, Phillips A. Hyaluronan orchestrates transforming growth factor-beta1-dependent maintenance of myofibroblast phenotype. J Biol Chem 284: 9083-9092, 2009.
39. Webber J, Jenkins RH, Meran S, Phillips A, Steadman R. Modulation of TGF beta1-dependent myofibroblast differentiation by hyaluronan. Am J Pathol 175: 148-160, 2009.
40. Weigel PH, DeAngelis PL. Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J Biol Chem 282: 36777-36781, 2007.
41. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 228: 1324-1346, 1985.
42. Yamasaki K, Muto J, Taylor KR, Cogen AL, Audish D, Bertin J, Grant EP, Coyle AJ, Misaghi A, Hoffman HM, Gallo RL. NLRP3/ cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 284: 12762-12771, 2009.